A carregar...

Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults

BACKGROUND: Liraglutide 3.0 mg, with diet and exercise, produced substantial weight loss over 1 year that was sustained over 2 years in obese non-diabetic adults. Nausea was the most frequent side effect. OBJECTIVE: To evaluate routinely collected data on nausea and vomiting among individuals on lir...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lean, M E J, Carraro, R, Finer, N, Hartvig, H, Lindegaard, M L, Rössner, S, Van Gaal, L, Astrup, A
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4010971/
https://ncbi.nlm.nih.gov/pubmed/23942319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ijo.2013.149
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!